Search for: "AstraZeneca"
Dr. Les Paul Joins Caris Life Sciences as Senior Vice President, Medical Affairs
HSMN NewsFeed,
31 Aug 2010:
Diagnostics, Personnel[Caris Life Sciences]
AstraZeneca Announces Agreements in Principle in SEROQUEL Product Liability Litigation
HSMN NewsFeed,
9 Aug 2010:
Biopharmaceuticals, Litigation[AstraZeneca, SEROQUEL]
FDA Advisory Committee Recommends US FDA Approval of Brilinta (Ticagrelor) for Acute Coronary Syndromes
HSMN NewsFeed,
28 Jul 2010:
Biopharmaceuticals, Cardiology, FDA[AstraZeneca, Brilinta, Ticagrelor, Acute Coronary Syndromes]
Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
HSMN NewsFeed,
7 Jul 2010:
Regenerative Medicine, Personnel[Tengion]
Mylan Receives Approval for Generic Version of Arimidex(R) Tablets
HSMN NewsFeed,
29 Jun 2010:
Biopharmaceuticals, Oncology, Generics, FDA[Mylan, Anastrozole, AstraZeneca, Arimidex, breast cancer]
APP Pharmaceuticals to Market Anastrozole Tablets in the U.S.
HSMN NewsFeed,
29 Jun 2010:
Biopharmaceuticals, Oncology[APP Pharmaceuticals, Fresenius Kabi Pharmaceuticals, Anastrozole, Arimidex]
Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)
HSMN NewsFeed,
22 Jun 2010:
Biopharmaceuticals, Generics, FDA[Hospira, meropenem, AstraZeneca, Merrem]
3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer
HSMN NewsFeed,
3 Jun 2010:
Biopharmaceuticals, Personnel[3-V Biosciences]
Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development
HSMN NewsFeed,
26 May 2010:
Biopharmaceuticals, Personnel[Pfizer]
Seattle Genetics Names Vice President, Sales and Announces Management Promotion
HSMN NewsFeed,
24 May 2010:
Biopharmaceuticals, Personnel[Seattle Genetics]
NOXXON Pharma AG appoints Dr. Aram Mangasarian as Chief Business Officer
HSMN NewsFeed,
18 May 2010:
Biopharmaceuticals, Personnel[NOXXON Pharma, Spiegelmers]
Teva Reaches Settlement Agreement With AstraZeneca Regarding Generic Entocort(R) EC Capsules
HSMN NewsFeed,
18 May 2010:
Biopharmaceuticals, Generics, Litigation[Teva Pharmaceutical, AstraZeneca, Entocort, budesonide]
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
HSMN NewsFeed,
3 May 2010:
Biopharmaceuticals, Drug Delivery, FDA[AstraZeneca, POZEN, VIMOVO, naproxen, esomeprazole]
Ethicon Endo-Surgery SEDASYS(R) System Receives Regulatory Approval in Canada and CE Mark in European Union
HSMN NewsFeed,
3 May 2010:
Devices, Gastroenterology, Regulatory[Ethicon Endo-Surgery, SEDASYS, colonoscopy]
CRESTOR(TM) Gains New EU Indication to Prevent Major Cardiovascular Events in High Risk Patients
HSMN NewsFeed,
27 Apr 2010:
Biopharmaceuticals, Cardiology[AstraZeneca, CRESTOR, rosuvastatin, JUPITER study]
MDRNA, Inc. Acquires Cequent Pharmaceuticals
HSMN NewsFeed,
1 Apr 2010:
Biopharmaceuticals, Mergers & Acquisitions[MDRNA, Cequent Pharmaceuticals]
AstraZeneca and Abbott Receive FDA Complete Response Letter on CERTRIAD(TM) New Drug Application
HSMN NewsFeed,
30 Mar 2010:
Biopharmaceuticals, FDA[Abbott, AstraZeneca, CERTRIAD]
Bristol-Myers Squibb and AstraZeneca Announce the Commencement of the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus Trial (SAVOR-TIMI 53)
HSMN NewsFeed,
9 Mar 2010:
Biopharmaceuticals, Cardiology, Endocrinology[Bristol-Myers Squibb, AstraZeneca, ONGLYZA, saxagliptin, diabetes]
Catalyst Biosciences Appoints William J. Dawson Chief Financial Officer
HSMN NewsFeed,
2 Mar 2010:
Biopharmaceuticals, Personnel[Catalyst Biosciences]
AstraZeneca Exercises Option to Acquire Merck's Interest in Partnership Products
HSMN NewsFeed,
1 Mar 2010:
Biopharmaceuticals, Acquisitions[Merck, AstraZeneca, Atacand, Lexxel, Plendil, Entocort, Nexium]
AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis (RA)
HSMN NewsFeed,
16 Feb 2010:
Biopharmaceuticals, Licensing[Rigel Pharmaceuticals, AstraZeneca, fostamatinib, rheumatoid arthritis]
AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
HSMN NewsFeed,
18 Jan 2010:
Personalized Medicine, Diagnostics, Biopharmaceuticals[AstraZeneca, Dako Denmark]
Adolor Corporation Announces Management Appointments
HSMN NewsFeed,
14 Jan 2010:
Biopharmaceuticals, Personnel[Adolor]
AstraZenenca and CrystalGenomics, Inc. Form Research Collaboration to Develop Novel Anti-Infective Treatments
HSMN NewsFeed,
13 Jan 2010:
Biopharmaceuticals[CrystalGenomics, AstraZenenca]
VentiRx Pharmaceuticals Raises $25 Million in Series A Extension Financing
HSMN NewsFeed,
12 Jan 2010:
Biopharmaceuticals, Venture Capital[VentiRx Pharmaceuticals]
Teva Announces Settlement Agreements with AstraZeneca Regarding Generic Prilosec(R) and Nexium(R)
HSMN NewsFeed,
7 Jan 2010:
Biopharmaceuticals, Generics, Litigation[Teva Pharmaceutical, AstraZeneca, Prilosec, omeprazole, Nexium, esomeprazole]
Forest Laboratories Announces Acquisition of Additional Rights Related to NXL 104, a Novel Broad-Spectrum Beta-Lactamase Inhibitor
HSMN NewsFeed,
23 Dec 2009:
Biopharmaceuticals, Licensing[Forest Laboratories, NXL 104, Beta-Lactamase Inhibitor, antibiotic]
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
HSMN NewsFeed,
16 Dec 2009:
Biopharmaceuticals, Mergers & Acquisitions, Personnel[Intradigm, Silence Therapeutics, RNA interference, RNAi]
Seattle Genetics and Millennium: The Takeda Oncology Company Announce Strategic Collaboration for Novel Late-Stage Lymphoma Program Brentuximab Vedotin (SGN-35)
HSMN NewsFeed,
15 Dec 2009:
Biopharmaceuticals, Oncology[Seattle Genetics, Millennium, Takeda Pharmaceutical, brentuximab vedotin]
Dennis Winger Joins Nektar Therapeutics' Board of Directors
HSMN NewsFeed,
14 Dec 2009:
Biopharmaceuticals, Personnel[Nektar Therapeutics]
Cubist Pharmaceuticals to Acquire Calixa Therapeutics
HSMN NewsFeed,
14 Dec 2009:
Biopharmaceuticals, Mergers & Acquisitions[Cubist Pharmaceuticals, Calixa Therapeutics]
Trial Date Set for CUBICIN(R) Patent Litigation
HSMN NewsFeed,
11 Dec 2009:
Biopharmaceuticals, Generics, Litigation[Cubist Pharmaceuticals, Teva Pharmaceutical, daptomycin, CUBICIN]
Epizyme Closes $40M Series B Financing
HSMN NewsFeed,
8 Dec 2009:
Biopharmaceuticals, Venture Capital[Epizyme]
US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder
HSMN NewsFeed,
4 Dec 2009:
Biopharmaceuticals, FDA[AstraZeneca, SEROQUEL XR, quetiapine, Major Depressive Disorder]
AstraZeneca Submits US New Drug Application for Ticagrelor (BRILINTA(TM)), an Investigational Antiplatelet Agent
HSMN NewsFeed,
19 Nov 2009:
Biopharmaceuticals, Cardiology[AstraZeneca, ticagrelor, BRILINTA, acute coronary syndrome, PLATO]
Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
HSMN NewsFeed,
13 Nov 2009:
Biopharmaceuticals, Personnel[Eli Lilly]
EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
HSMN NewsFeed,
6 Nov 2009:
Biopharmaceuticals, Personnel[EpiCept]
Seattle Genetics Names Head of Commercial and Announces Management Promotion
HSMN NewsFeed,
13 Oct 2009:
Biopharmaceuticals, Personnel[Seattle Genetics]
Arginetix Closes $10.75 Million Series A Financing
HSMN NewsFeed,
2 Oct 2009:
Biopharmaceuticals, Venture Capital[Arginetix]
Teva Provides Update on Generic Seroquel(R) Litigation
HSMN NewsFeed,
25 Sep 2009:
Biopharmaceuticals, Generics, Litigation[Teva Pharmaceutical, Seroquel, quetiapine]
Ticagrelor Reduced Cardiovascular Deaths and Heart Attacks in ACS Patients Undergoing Heart Procedures: New Data from PLATO Trial
HSMN NewsFeed,
24 Sep 2009:
Biopharmaceuticals, Cardiology[AstraZeneca, PLATO study, BRILINTA, ticagrelor, antiplatelet treatment]
Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
HSMN NewsFeed,
16 Sep 2009:
Biopharmaceuticals, Personnel[Rib-X Pharmaceuticals, antibiotic]
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
HSMN NewsFeed,
14 Sep 2009:
Biopharmaceuticals, Personnel[POZEN]
Ventana Enters Into a Multi Billion Dollar Market
HSMN NewsFeed,
27 Aug 2009:
Biopharmaceuticals[Ventana Biotech, stress-suppressing chewing gum, stress hormone]
Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Late Stage Next Generation Anti-Infective
HSMN NewsFeed,
12 Aug 2009:
Biopharmaceuticals[Forest Laboratories, AstraZeneca, cSSSI, Ceftaroline]
Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL(R) 25 MG and 50 MG
HSMN NewsFeed,
3 Aug 2009:
Biopharmaceuticals, Generics, FDA[Watson Pharmaceuticals, Watson Laboratories, metoprolol, AstraZeneca, Toprol XL]
AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
HSMN NewsFeed,
30 Jul 2009:
Biopharmaceuticals, Oncology[AstraZeneca, vandetanib, ZACTIMA, lung cancer]
Onset Therapeutics Announces Additions to Senior Management Team
HSMN NewsFeed,
27 Jul 2009:
Biopharmaceuticals, Dermatology, Personnel[Onset Therapeutics]
MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
HSMN NewsFeed,
9 Jul 2009:
Biopharmaceuticals[MAP Pharmaceuticals, AstraZeneca, Budesonide, asthma]
Mylan Receives FDA Approval for Generic Version of Prostate Cancer Treatment Casodex(R)
HSMN NewsFeed,
7 Jul 2009:
Biopharmaceuticals, Generics, Oncology, FDA[Mylan, Bicalutamide, AstraZeneca, Casodex, prostate cancer]
Abbott and AstraZeneca Extend Relationship to Include Co-Promotion of TRILIPIX(R) (fenofibric acid)
HSMN NewsFeed,
4 Jun 2009:
Biopharmaceuticals[Abbott, AstraZeneca, TRILIPIX, fenofibric acid]
Abbott and AstraZeneca Submit New Drug Application to the FDA for CERTRIAD(TM), an Investigational Treatment for Mixed Dyslipidemia
HSMN NewsFeed,
4 Jun 2009:
Biopharmaceuticals[Abbott, AstraZeneca, mixed dyslipidemia, CERTRIAD]
MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
HSMN NewsFeed,
26 May 2009:
Biopharmaceuticals[MAP Pharmaceuticals, LEVADEX, MAP0004, migraine]
Budesonide/Formoterol Plus Tiotropium Improves the Quality of Life of Patients With Severe COPD
HSMN NewsFeed,
21 May 2009:
Biopharmaceuticals[AstraZeneca, budesonide/formoterol, Symbicort]
AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
HSMN NewsFeed,
18 May 2009:
Biopharmaceuticals[AstraZeneca, TOPROL-XL, Metoprolol]
The Medicines Company Discontinues Phase 3 CHAMPION Clinical Trial Program of Cangrelor
HSMN NewsFeed,
13 May 2009:
Biopharmaceuticals, Cardiology[The Medicines Company, cangrelor, CHAMPION-PCI]
AstraZeneca Secures Approval for Nexium (esomeprazole) In Peptic Ulcer Bleeding
HSMN NewsFeed,
12 May 2009:
Biopharmaceuticals, Gastroenterology, Regulatory[AstraZeneca, Nexium, esomeprazole, peptic ulcer]
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
HSMN NewsFeed,
4 May 2009:
Biopharmaceuticals[AstraZeneca, esomeprazole, NEXIUM]
U.S. Food and Drug Administration Extends Review Timeline for ONGLYZA (saxagliptin) New Drug Application
HSMN NewsFeed,
23 Apr 2009:
Biopharmaceuticals, Endocrinology, FDA[Bristol-Myers Squibb, AstraZenec, ONGLYZA, saxagliptin, diabetes]
Seattle Genetics Receives FDA Fast Track Designation for SGN-35 for the Treatment of Hodgkin Lymphoma
HSMN NewsFeed,
30 Mar 2009:
Biopharmaceuticals, Oncology, FDA[Seattle Genetics, SGN-35, Hodgkin lymphoma, Hodgkin's lymphoma]
MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
HSMN NewsFeed,
23 Feb 2009:
Biopharmaceuticals[MAP Pharmaceuticals, AstraZeneca, Budesonide, asthma]
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
HSMN NewsFeed,
23 Feb 2009:
Biopharmaceuticals[AstraZeneca, SEROQUEL XR, quetiapine, Bipolar depression]
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
HSMN NewsFeed,
23 Feb 2009:
Biopharmaceuticals, Personnel[Micromet , blinatumomab]
CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study
HSMN NewsFeed,
19 Feb 2009:
Biopharmaceuticals, Cardiology[AstraZeneca, JUPITER study, CRESTOR, rosuvastatin]
Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market
HSMN NewsFeed,
5 Feb 2009:
Biopharmaceuticals, Generics, FDA[Dr. Reddy's Laboratories, Levetiracetam, Omeprazole, Lamotragine, Divalproex]
POZEN Informed by FDA That Endoscopic Gastric Ulcer Incidence Continues to Be an Acceptable Primary Endpoint
HSMN NewsFeed,
29 Jan 2009:
Biopharmaceuticals, FDA[POZEN, AstraZeneca, PN 400, naproxen, esomeprazole, arthritis]
IMPAX Receives Final FDA Approval for Omeprazole 40 mg Capsules
HSMN NewsFeed,
23 Jan 2009:
Biopharmaceuticals, Generics, FDA[IMPAX Laboratories, Omeprazole, AstraZeneca, Prilosec, gastroesophageal reflux]
Mylan Receives Final FDA Approval for Generic Version of Prilosec(R) Delayed-Release Capsules, 40 mg
HSMN NewsFeed,
23 Jan 2009:
Biopharmaceuticals, Generics, FDA[Mylan, Omeprazole, AstraZeneca, Prilosec, gastroesophageal reflux disease]
Hydra Biosciences Raises $22 Million in Series D Financing
HSMN NewsFeed,
16 Jan 2009:
Biopharmaceuticals, Venture Capital[Hydra Biosciences]
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
HSMN NewsFeed,
13 Jan 2009:
Biopharmaceuticals, Personnel[Jennerex]
MedImmune Submits Marketing Authorisation Application in European Union for Intranasal Vaccine to Prevent Seasonal Influenza
HSMN NewsFeed,
6 Jan 2009:
Biopharmaceuticals, Regulatory[MedImmune, AstraZeneca, influenza, LAIV]
AstraZeneca Submits sNDA for NEXIUM(R) for the Short-Term Treatment of GERD in Infants 0 to 1 Year Old
HSMN NewsFeed,
19 Dec 2008:
Biopharmaceuticals, Gastroenterology[AstraZeneca, NEXIUM, esomeprazole, gastroesophageal reflux disease]
Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management
HSMN NewsFeed,
15 Dec 2008:
Biopharmaceuticals, FDA[Abbott, TRILIPIX, fenofibric acid]
Algeta Appoints Andrew Kay as President and Chief Executive Officer
HSMN NewsFeed,
11 Dec 2008:
Biopharmaceuticals, Personnel[Algeta ASA]
NovaRx Appoints Industry Veteran as President and COO
HSMN NewsFeed,
4 Dec 2008:
Biopharmaceuticals, Personnel[NovaRx]
AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America
HSMN NewsFeed,
3 Dec 2008:
Biopharmaceuticals, Personnel[AstraZeneca]
Cubist Names Santosh J. Vetticaden as SVP, Clinical Development and Chief Medical Officer
HSMN NewsFeed,
2 Dec 2008:
Biopharmaceuticals, Personnel[Cubist Pharmaceuticals]
Teva Provides Update on Generic Pulmicort RespulesŽ Launch
HSMN NewsFeed,
20 Nov 2008:
Biopharmaceuticals, Generics[Teva Pharmaceutical, AstraZeneca, Pulmicort Respules, Budesonide]
AstraZeneca Appoints Rich Fante as President of its U.S. Business
HSMN NewsFeed,
18 Nov 2008:
Biopharmaceuticals, Personnel[AstraZeneca]
MedImmune Announces Zook as President
HSMN NewsFeed,
13 Nov 2008:
Biopharmaceuticals, Personnel[MedImmune]
BD Announces Executive Appointments of President and Chief Financial Officer
HSMN NewsFeed,
5 Nov 2008:
Devices, Personnel[Becton Dickinson]
Abraxis BioScience and Specialised Therapeutics Australia Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in Australia
HSMN NewsFeed,
16 Oct 2008:
Biopharmaceuticals, Oncology, Regulatory[Abraxis BioScience, ABRAXANE, paclitaxel, metastatic breast cancer]
FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
HSMN NewsFeed,
10 Oct 2008:
Biopharmaceuticals, FDA[AstraZeneca, SEROQUEL XR, quetiapine]
Seattle Genetics Adds to Senior Management Team
HSMN NewsFeed,
30 Sep 2008:
Biopharmaceuticals, Personnel[Seattle Genetics]
4-Antibody Appoints Dr. Richard Mason as New Chief Executive Officer
HSMN NewsFeed,
26 Sep 2008:
Biopharmaceuticals, Personnel[4-Antibody]
US Court Denies Teva's Motion for Summary Judgment in PULMICORT RESPULES(R) Patent Litigation
HSMN NewsFeed,
23 Sep 2008:
Biopharmaceuticals, Generics, FDA[AstraZeneca, PULMICORT RESPULES, Teva Pharmaceutical]
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
HSMN NewsFeed,
12 Sep 2008:
Biopharmaceuticals, Cardiology, Licensing[CV Therapeutics, Menarini Group, Ranexa, ranolazine]
Monoclonal Antibody Sales to Almost Double in Coming Years
HSMN NewsFeed,
30 Aug 2008:
Biopharmaceuticals[Monoclonal Antibody]
Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
HSMN NewsFeed,
14 Aug 2008:
Biopharmaceuticals[Abbott, AstraZeneca, CRESTOR, rosuvastatin]
Dynavax and Merck & Co., Inc. Announce Phase 3 Trial with Investigational Hepatitis B Vaccine (HEPLISAV(TM)) Met its Primary Endpoint
HSMN NewsFeed,
5 Aug 2008:
Biopharmaceuticals[Dynavax Technologies, Merck, HEPLISAV, hepatitis B]
Inhaler Devices are Still a Major Hurdle in Asthma and COPD Treatment
HSMN NewsFeed,
2 Aug 2008:
Biopharmaceuticals, Devices, Drug Delivery[Datamonitor, asthma, COPD]
Lung Cancer Epidemic Looming in Asia?
HSMN NewsFeed,
2 Aug 2008:
Biopharmaceuticals, Oncology[Datamonitor, non-small cell lung cancer]
Ranbaxy Launches Omeprazole 40 mg Capsules
HSMN NewsFeed,
28 Jul 2008:
Biopharmaceuticals, Generics[Ranbaxy Pharmaceuticals, AstraZeneca, Omeprazole, Prilosec]
Bristol-Myers Squibb and AstraZeneca Submit New Drug Application in the United States and Marketing Authorization Application in Europe for ONGLYZA(TM) (saxagliptin) for the Treatment of Type 2 Diabetes
HSMN NewsFeed,
23 Jul 2008:
Biopharmaceuticals, FDA, Endocrinology[Bristol-Myers Squibb, AstraZeneca, ONGLYZA, saxagliptin, diabetes]
BG Medicine Closes $40 Million in Series D Financing
HSMN NewsFeed,
17 Jul 2008:
Diagnostics, Venture Capital[BG Medicine]
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in China
HSMN NewsFeed,
14 Jul 2008:
Biopharmaceuticals, Oncology, Regulatory[Abraxis BioScience, ABRAXANE, Paclitaxel, breast cancer]
Royalty Pharma Announces that James Reddoch, Ph.D., Joins Management Team
HSMN NewsFeed,
8 Jul 2008:
Biopharmaceuticals, Personnel[Royalty Pharma]
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.
HSMN NewsFeed,
2 Jul 2008:
Biopharmaceuticals[Cubist Pharmaceuticals, AstraZeneca, MERREM, meropenem, antibiotic]
Teva Provides Update on Generic Seroquel(R) Litigation
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Generics, Litigation[Teva Pharmaceutical, Quetiapine, AstraZeneca, Seroquel]
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Elavil(R)
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Generics, FDA[Caraco Pharmaceutical, Amitriptyline, Elavil, AstraZeneca]
Mylan Wins Generic Prilosec(R) Patent Litigation
HSMN NewsFeed,
10 Jun 2008:
Biopharmaceuticals, Generics, Litigation[Mylan, AstraZeneca, Omeprazole, Prilosec]
Senior Pharmaceutical Executive, Glenn J. Gormley, M.D., Ph.D., to Lead Gemin X Pharmaceuticals as President and CEO
HSMN NewsFeed,
10 Jun 2008:
Biopharmaceuticals, Personnel[Gemin X Pharmaceuticals]
AstraZeneca Submits an sNDA for SYMBICORT(R) for the Treatment of Asthma in Children as Young as Age Six
HSMN NewsFeed,
4 Jun 2008:
Biopharmaceuticals, FDA[AstraZeneca, SYMBICORT, budesonide, formoterol, asthma]
ABRAXANE(R) in Combination with Trastuzumab and Carboplatin Evaluated as First-Line Treatment for Patients with HER2-Positive Metastatic Breast Cancer
HSMN NewsFeed,
2 Jun 2008:
Biopharmaceuticals, Oncology[Abraxis BioScience, ABRAXANE, paclitaxel, Trastuzumab, breast cancer]
Combination Therapy of Solvent-Free ABRAXANE(R) and the Targeted Therapy Bevacizumab Evaluated as First-Line Treatment for Metastatic Breast Cancer
HSMN NewsFeed,
2 Jun 2008:
Biopharmaceuticals, Oncology[Abraxis BioScience, ABRAXANE, paclitaxel, bevacizumab, breast cancer]
Watson Receives Final Approval of Omeprazole Delayed-Release Capsules
HSMN NewsFeed,
2 Jun 2008:
Biopharmaceuticals, Generics, FDA[Watson Pharmaceuticals, Omeprazole, AstraZeneca, Prilosec]
Phase III Study of Abbott's Investigational TriLipix(TM) in Combination With AstraZeneca's CRESTOR(R) Meets Primary Endpoints on Key Lipids
HSMN NewsFeed,
31 May 2008:
Biopharmaceuticals, Cardiology[Abbott, TriLipix, ABT-335, AstraZeneca, CRESTOR, rosuvastatin]
"The Group Room(R)" to Broadcast 10th Anniversary Show From the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO), Sunday, June 1
HSMN NewsFeed,
29 May 2008:
Oncology[Vital Options, The Group Room]
Endo Pharmaceuticals Appoints Blaine T. Davis as Vice President, Investor Relations and Corporate Communications
HSMN NewsFeed,
22 May 2008:
Biopharmaceuticals, Personnel[Endo Pharmaceuticals]
KV Pharmaceutical Company Announces Approval for the 50 mg Strength of Generic Version of Toprol-XL(R)
HSMN NewsFeed,
15 May 2008:
Biopharmaceuticals, Generics, FDA[KV Pharmaceutical, Metoprolol, AstraZeneca, Toprol-XL]
FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
HSMN NewsFeed,
14 May 2008:
Biopharmaceuticals, FDA[AstraZeneca, SEROQUEL, quetiapine, bipolar disorder]
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Generalized Anxiety Disorder - a First for the Atypical Antipsychotic Class of Medicines
HSMN NewsFeed,
8 May 2008:
Biopharmaceuticals[AstraZeneca, SEROQUEL XR, quetiapine, generalized anxiety disorder]
MedImmune Fortifies Strategic Scientific Portfolio Management and International Leadership With New Executive Appointments
HSMN NewsFeed,
6 May 2008:
Biopharmaceuticals, Personnel[MedImmune]
Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
HSMN NewsFeed,
5 May 2008:
Devices, Interventional[Volcano, intravascular ultrasound, SATURN, Volcano Revolution]
Abraxis BioScience Reports Promising Clinical Data in Advanced Pancreatic Cancer Using a Combination of nab-Paclitaxel (ABRAXANE(R)) and Gemcitabine (Gemzar(R))
HSMN NewsFeed,
23 Apr 2008:
Biopharmaceuticals, Oncology[Abraxis BioScience, ABRAXANE, paclitaxel, pancreatic cancer]
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
HSMN NewsFeed,
21 Apr 2008:
Biopharmaceuticals, FDA, Generics[Mylan, Felodipine, AstraZeneca, Plendil]
Dynavax and Merck & Co., Inc. Update Status of Clinical Hold of Investigational Vaccine HEPLISAV(TM)
HSMN NewsFeed,
17 Apr 2008:
Biopharmaceuticals, FDA[Dynavax Technologies, Merck, HEPLISAV, vaccine, hepatitis B]
Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation
HSMN NewsFeed,
15 Apr 2008:
Biopharmaceuticals, Generics, Litigation, Distribution[Ranbaxy, AstraZeneca, Nexium, Esomeprazole, Felodipine]
Abraxis BioScience Announces Approval to Market ABRAXANE for Metastatic Breast Cancer in Korea
HSMN NewsFeed,
9 Apr 2008:
Biopharmaceuticals, Oncology, Regulatory[Abraxis BioScience, ABRAXANE, paclitaxel, breast cancer]
Collegium Pharmaceutical Announces FDA Filing for AllerNase(TM), a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis
HSMN NewsFeed,
8 Apr 2008:
Biopharmaceuticals, FDA[Collegium Pharmaceutical, AllerNase, triamcinolone acetonide, allergic rhinitis]
First Statin Monotherapy to Achieve Regression of Coronary Atherosclerosis by Angiography in a Major Clinical Study
HSMN NewsFeed,
31 Mar 2008:
Biopharmaceuticals, Cardiology[AstraZeneca, CRESTOR, rosuvastatin, ASTEROID study]
Ethicon Endo-Surgery Submits Application to FDA for Approval of the SEDASYS(TM) System - the First Computer-Assisted Personalized Sedation System
HSMN NewsFeed,
27 Mar 2008:
Devices, Drug Delivery, Gastroenterology, FDA[Ethicon Endo-Surgery, SEDASYS, propofol, colonoscopy]
Stem Cell Technology Offers Promise of Huge Savings for Drug Developers
HSMN NewsFeed,
20 Mar 2008:
Biopharmaceuticals, Regenerative Medicine[Kalorama Information, stem cell, cord blood]
Dynavax and Merck & Co., Inc. Report Clinical Hold of Investigational Vaccine HEPLISAV
HSMN NewsFeed,
17 Mar 2008:
Biopharmaceuticals[Dynavax Technologies, Merck, HEPLISAV, hepatitis B]
Abraxis Bioscience Announces Filing of Marketing Application in Japan for ABRAXANE in the Treatment of Breast Cancer
HSMN NewsFeed,
17 Mar 2008:
Biopharmaceuticals, Oncology, Regulatory[Abraxis BioScience, ABRAXANE, paclitaxel, breast cancer]
AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
HSMN NewsFeed,
12 Mar 2008:
Biopharmaceuticals, Oncology[AstraZeneca, vandetanib, NSCLC, ZODIAC, ZEAL]
Cayenne Closes $15 Million Series C Financing
HSMN NewsFeed,
6 Mar 2008:
Devices, Orthopaedic, Venture Capital[Cayenne Medical, AperFix, ACL reconstruction]
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
HSMN NewsFeed,
29 Feb 2008:
Biopharmaceuticals[AstraZeneca, SEROQUEL XR, quetiapine, major depressive disorder]
FDA Approves NEXIUM(R) for the Treatment of Short-Term GERD in Children 1 to 11 Years Old
HSMN NewsFeed,
28 Feb 2008:
Biopharmaceuticals, Gastroenterology, FDA[AstraZeneca, NEXIUM, esomeprazole, gastroesophageal reflux disease]
Merck Retains Interest in AstraZeneca LP Products
HSMN NewsFeed,
28 Feb 2008:
Biopharmaceuticals, Gastroenterology[Merck, AstraZeneca, Atacand, Lexxel, Plendil, Entocort]
Bentley Pharmaceuticals Announces Product Approvals in Europe
HSMN NewsFeed,
13 Feb 2008:
Biopharmaceuticals, Generics, Regulatory[Bentley Pharmaceuticals, omeprazole, Prilosec, Losec, AstraZeneca]
MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio
HSMN NewsFeed,
7 Feb 2008:
Biopharmaceuticals, Personnel[MedImmune]
Ranbaxy Receives Tentative Approval to Manufacture and Market Esomeprazole Magnesium DR Capsules
HSMN NewsFeed,
7 Feb 2008:
Biopharmaceuticals, FDA, Generics[Ranbaxy Pharmaceuticals, Esomeprazole, Nexium, AstraZeneca]
Abraxis Bioscience Establishes Global Leadership Team
HSMN NewsFeed,
7 Feb 2008:
Biopharmaceuticals, Personnel[Abraxis BioScience]
MedImmune Submits Biologics License Application to FDA for Motavizumab
HSMN NewsFeed,
4 Feb 2008:
Biopharmaceuticals[MedImmune, motavizumab, respiratory syncytial virus]
Infinity and MedImmune Announce Approval for Generic Name for Novel Hsp90 Inhibitor
HSMN NewsFeed,
4 Feb 2008:
Biopharmaceuticals, Oncology[Infinity Pharmaceuticals, MedImmune, retaspimycin, heat shock protein]
Palatin Technologies Announces Litigation Settlement With Competitive Technologies
HSMN NewsFeed,
22 Jan 2008:
Biopharmaceuticals, Licensing, Litigation[Palatin Technologies, Competitive Technologies, bremelanotide]
Abraxis Receives Approval from EU Commission to Market ABRAXANE for Metastatic Breast Cancer in Europe
HSMN NewsFeed,
22 Jan 2008:
Biopharmaceuticals, Oncology, Regulatory[Abraxis BioScience, ABRAXANE, paclitaxel, breast cancer]
POZEN Submits Human Lymphocyte Study for Treximet(TM) (Formerly Known as Trexima(TM))
HSMN NewsFeed,
15 Jan 2008:
Biopharmaceuticals, FDA[POZEN, GlaxoSmithKline, Treximet, Trexima]
First Head to Head Study Comparing Crestor(TM) and Lipitor(R) Effects on the Treatment of Atherosclerosis
HSMN NewsFeed,
15 Jan 2008:
Biopharmaceuticals, Cardiology[AstraZeneca, SATURN trial, CRESTOR, Lipitor, atherosclerosis]
MedImmune Broadens Focus of Venture Capital Fund to Include New Therapeutic Areas
HSMN NewsFeed,
7 Jan 2008:
Venture Capital[MedImmune, AstraZeneca, MedImmune Ventures]
MedImmune Expands Scientific and Engineering Leadership
HSMN NewsFeed,
20 Dec 2007:
Biopharmaceuticals, Personnel[MedImmune]
Anastrozole Confirmed Superior in Breast Cancer Prevention
HSMN NewsFeed,
14 Dec 2007:
Biopharmaceuticals, Oncology[AstraZeneca, ARIMIDEX, anastrozole, breast cancer]
Alnylam Appoints Barry Greene President and Chief Operating Officer
HSMN NewsFeed,
14 Dec 2007:
Biopharmaceuticals, Personnel[Alnylam Pharmaceuticals]
FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
HSMN NewsFeed,
10 Dec 2007:
Biopharmaceuticals[AstraZeneca, esomeprazole, NEXIUM]
Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
HSMN NewsFeed,
5 Dec 2007:
Biopharmaceuticals[Bristol-Myers Squibb]
Medicure Announces Appointment to Board of Directors
HSMN NewsFeed,
5 Dec 2007:
Biopharmaceuticals, Personnel[Medicure]
Pharmaxis Commences Operations in United States
HSMN NewsFeed,
4 Dec 2007:
Biopharmaceuticals, Personnel[Pharmaxis]
Dr. Warren Wasiewski Appointed Chief Medical Officer of Neurobiological Technologies, Inc.
HSMN NewsFeed,
28 Nov 2007:
Biopharmaceuticals, Personnel[Neurobiological Technologies]
Orexo Announces New Executive Management Team
HSMN NewsFeed,
26 Nov 2007:
Biopharmaceuticals, Personnel[Orexo]
SEROQUEL XR(TM) Receives Approval From FDA for Maintenance Treatment of Schizophrenia
HSMN NewsFeed,
16 Nov 2007:
Biopharmaceuticals, FDA[AstraZeneca, SEROQUEL XR, quetiapine, schizophrenia]
Atlantis Abutments in Zirconia Now Available for Astra Tech OsseoSpeed(TM) Implants
HSMN NewsFeed,
15 Nov 2007:
Devices, Dental[Atlantis Components, Astra Tech, AstraZeneca, OsseoSpeed, dental abutment]
AstraZeneca Appoints Kenneth L. Murtha as Regional Supply VP for the Americas
HSMN NewsFeed,
12 Nov 2007:
Biopharmaceuticals, Personnel[AstraZeneca]
Verus Pharmaceuticals Announces Promotion of Robert W. Keith to Chief Executive Officer
HSMN NewsFeed,
12 Nov 2007:
Biopharmaceuticals, Personnel[Verus Pharmaceuticals]
CRESTOR(R) Now Indicated to Slow the Progression of Atherosclerosis in Patients With Elevated Cholesterol
HSMN NewsFeed,
9 Nov 2007:
Biopharmaceuticals, FDA, Cardiology[AstraZeneca, CRESTOR, rosuvastatin, atherosclerosis]
New Analysis of METEOR Study Demonstrate Effects of AstraZeneca's CRESTOR(R) (Rosuvastatin Calcium) on Atherosclerosis in Patients With Two or More Risk Factors for Cardiovascular Disease
HSMN NewsFeed,
7 Nov 2007:
Biopharmaceuticals, Cardiology[AstraZeneca, METEOR trial, CRESTOR, rosuvastatin, CIMT]
MedImmune Announces Seven Key Promotions and New Hires
HSMN NewsFeed,
5 Nov 2007:
Biopharmaceuticals, Personnel[MedImmune]
New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure
HSMN NewsFeed,
5 Nov 2007:
Biopharmaceuticals, Cardiology[AstraZeneca, CRESTOR, rosuvastatin]
Acusphere to Develop Potential Abraxane(R) Bioequivalent
HSMN NewsFeed,
2 Nov 2007:
Biopharmaceuticals, Drug Delivery[Acusphere, Abraxane, paclitaxel, microsphere]
Pozen Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA
HSMN NewsFeed,
1 Nov 2007:
Biopharmaceuticals, FDA[POZEN, Trexima, Sumatriptan]
Perrigo Announces that Dexcel's Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
HSMN NewsFeed,
1 Nov 2007:
Biopharmaceuticals, Generics, Litigation[Perrigo, Dexcel Pharma Technologies, AstraZeneca, Omeprazole, Prilosec]
Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
HSMN NewsFeed,
1 Nov 2007:
Biopharmaceuticals[Dynavax Technologies, Merck, hepatitis B , HEPLISAV]
David Mott Appointed Non Executive Director at Shire
HSMN NewsFeed,
31 Oct 2007:
Biopharmaceuticals, Personnel[Shire plc]
NPS Pharmaceuticals Names Douglas N. Dobak Vice President of Regulatory Affairs and Drug Safety
HSMN NewsFeed,
30 Oct 2007:
Biopharmaceuticals, Personnel[NPS Pharmaceuticals]
AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
HSMN NewsFeed,
29 Oct 2007:
Biopharmaceuticals[MedImmune, Cambridge Antibody Technology, AstraZeneca]
Abraxis BioScience and Biocon Limited Announce Approval of ABRAXANE in India for the Treatment of Breast Cancer
HSMN NewsFeed,
18 Oct 2007:
Biopharmaceuticals, Oncology, Regulatory[Abraxis BioScience, Biocon Limited, ABRAXANE, paclitaxel, breast cancer]
Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
HSMN NewsFeed,
16 Oct 2007:
Biopharmaceuticals, Gastroenterology[AstraZeneca, NEXIUM, esomeprazole, gastroesophageal reflux disease]
POZEN Submits Response to Approvable Letter for Trexima(TM)
HSMN NewsFeed,
15 Oct 2007:
Biopharmaceuticals, FDA[POZEN, GlaxoSmithKline, Trexima, sumatriptan, naproxen]
POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days
HSMN NewsFeed,
5 Oct 2007:
Biopharmaceuticals[POZEN, GlaxoSmithKline, Trexima]
Pediatric Asthma Programs With CyDex Captisol Technology Acquired by AstraZeneca
HSMN NewsFeed,
3 Oct 2007:
Biopharmaceuticals, Drug Delivery, Acquisitions[CyDex, Verus Pharmaceuticals, AstraZeneca, Captisol, asthma]
Palatin Technologies Announces Reduction of Workforce
HSMN NewsFeed,
26 Sep 2007:
Biopharmaceuticals[Palatin Technologies, bremelanotide]
MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
HSMN NewsFeed,
24 Sep 2007:
Biopharmaceuticals, Licensing[MedImmune, GlaxoSmithKline, influenza vaccine]
Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
HSMN NewsFeed,
20 Sep 2007:
Biopharmacetuicals, Oncology[AstraZeneca, vandetanib, ZACTIMA, Non Small Cell Lung Cancer]
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
HSMN NewsFeed,
19 Sep 2007:
Biopharmaceuticals[Dynavax Technologies, HEPLISAV, hepatitis B]
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
HSMN NewsFeed,
19 Sep 2007:
Biopharmaceuticals, FDA[MedImmune, FluMist, Influenza Virus Vaccine]
Infinity and MedImmune Receive Orphan Drug Designation for IPI-504 for Treatment of Gastroinstestinal Stromal Tumors
HSMN NewsFeed,
17 Sep 2007:
Biopharmaceuticals, Oncology, FDA[Infinity Pharmaceuticals, MedImmune, orphan drug designation, IPI-504]
Micromet Appoints Mark Reisenauer as Senior Vice President and Chief Commercial Officer
HSMN NewsFeed,
12 Sep 2007:
Biopharmaceuticals, Personnel[Micromet]
Abbott and AstraZeneca Announce Selection of Next-Generation Fenofibrate ABT-335 and CRESTOR(R) Fixed-Dose Combination
HSMN NewsFeed,
31 Aug 2007:
Biopharmaceuticals[Abbott, AstraZeneca, ABT-335, fenofibrate, CRESTOR, rosuvastatin]
King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
HSMN NewsFeed,
30 Aug 2007:
Biopharmaceuticals[Palatin Technologies, King Pharmaceuticals, bremelanotide, erectile dysfunction]
Collegium Pharmaceutical Provides Update on Development of its Nasal Inhaled Steroid for Allergic Rhinitis
HSMN NewsFeed,
15 Aug 2007:
Biopharmaceuticals[Collegium Pharmaceutical, Tri-Nasal, triamcinolone, allergic rhinitis]
APP Receives Expedited Approval for the First and Only Generic Cefotetan Disodium for Injection
HSMN NewsFeed,
10 Aug 2007:
Biopharmaceuticals, Generics, FDA[Abraxis BioScience, Cefotetan, AstraZeneca, Cefotan, cephalosporin]
Abraxis BioScience Announces Licensing Agreement with Biocon Limited for the Commercialization of ABRAXANE in India
HSMN NewsFeed,
8 Aug 2007:
Biopharmaceuticals, Oncology, Licensing[Abraxis BioScience, Biocon Limited, ABRAXANE]
PreMD Signs Marketing and Distribution Agreement with AstraZeneca
HSMN NewsFeed,
16 Jul 2007:
Diagnostics, Cardiology, Licensing, Distribution[PreMD, AstraZeneca, PREVU , skin cholesterol test]
Merck Names Peter Kellogg as Executive Vice President and Chief Financial Officer
HSMN NewsFeed,
29 Jun 2007:
Biopharmaceuticals, Personnel[Merck]
Coley Pharmaceutical Group Grants Dynavax License for Commercialization of HEPLISAV(TM)
HSMN NewsFeed,
28 Jun 2007:
Biopharmaceuticals, Licensing[Coley Pharmaceutical, Dynavax Technologies, HEPLISAV, hepatitis B, vaccine]
U.S. Supreme Court Denies Review of Tamoxifen Citrate Antitrust Lawsuits
HSMN NewsFeed,
25 Jun 2007:
Biopharmaceuticals, Generics, Litigation[Barr Pharmaceuticals, Tamoxifen, AstraZenca, Nolvadex]
AstraZeneca Announces SYMBICORT(R) is Now Available in the U.S.
HSMN NewsFeed,
25 Jun 2007:
Biopharmaceuticals[AstraZeneca, SYMBICORT, budesonide, formoterol, asthma]
Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
HSMN NewsFeed,
19 Jun 2007:
Biopharmaceuticals, Oncology[Myriad Genetics, BRCA1, BRCA2, ICEBERG, KuDOS Pharmaceuticals, breast cancer]
Judgment Enters in Favor of Proveris Scientific Corporation in Patent Infringement Lawsuit against InnovaSystems, Inc.
HSMN NewsFeed,
11 Jun 2007:
Devices, Drug Delivery, Litigation[Proveris Scientific, SprayVIEW, InnovaSystems]
Biodesix, Inc. Announces Breakthrough In Molecular Diagnostics For Lung Cancer
HSMN NewsFeed,
7 Jun 2007:
Diagnostics, Oncology[Biodesix, non-small cell lung cancer, VeriStrat]
New Data Shows Promising Antitumor Activity with nab-paclitaxel (ABRAXANE(R)) in Combination and as a Single Agent for the Treatment of Lung and Ovarian Cancers
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Oncology[Abraxis BioScience, ABRAXANE, paclitaxel, lung cancer, ovarian cancer]
Investigational Drug Cediranib (AZD2171) Shows Promise in Patients With Recurrent Glioblastoma (GBM)
HSMN NewsFeed,
4 Jun 2007:
Biopharmaceuticals, Oncology[AstraZeneca, cediranib, glioblastoma multiforme]
Next Generation of Investigational Anti-Cancer Agents Unveiled at ASCO by AstraZeneca
HSMN NewsFeed,
3 Jun 2007:
Biopharmaceuticals, Oncology[AstraZeneca, AZD2281, AZD0530]
Clinical Data Suggest Potential Versatility of ALIMTA(R) (Pemetrexed for Injection)-Based Regimens in Lung Cancer
HSMN NewsFeed,
2 Jun 2007:
Biopharmaceuticals, Oncology[Eli Lilly, ALIMTA, pemetrexed, non-small cell lung cancer]
ABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast Cancer
HSMN NewsFeed,
2 Jun 2007:
Biopharmaceuticals, Oncology[Abraxis BioScience, ABRAXANE, paclitaxel, Breast Cancer]
IMPAX Announces Decision on Generic Prilosec(R) Litigation
HSMN NewsFeed,
1 Jun 2007:
Biopharmaceuticals, Generics, Litigation[IMPAX Laboratories, AstraZeneca, Prilosec, omeprazole]
New Data Highlighting ABRAXANE as Single Agent and in Combination for the Treatment of Breast, Lung and Ovarian Cancers to Be Presented at ASCO
HSMN NewsFeed,
30 May 2007:
Biopharmaceuticals, Drug Delivery, Oncology[Abraxis BioScience, ABRAXANE, paclitaxel]
"The Group Room(R)" to Broadcast 10th Anniversary Show From the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO), Sunday, June 3
HSMN NewsFeed,
29 May 2007:
Oncology[Vital Options International, Group Room, American Society of Clinical Oncology]
Sandoz Receives FDA Approval for Generic Toprol XL(R) 50 mg Tablet
HSMN NewsFeed,
21 May 2007:
Biopharmaceuticals, Generics, FDA[Sandoz, metoprolol, Toprol, AstraZeneca]
Watson Enters Into Agreement to Permit Sandoz to Launch Metoprolol Succinate Extended-Release 50 mg Tablets; Relinquishes 180-Day Market Exclusivity
HSMN NewsFeed,
21 May 2007:
Biopharmaceuticals, Generics[Watson Pharmaceuticals, Sandoz, Novartis, metoprolol, AstraZeneca, Toprol XL]
KV Pharmaceutical Company Announces Approval for Two Strengths of Generic Versions of Toprol-XL(R)
HSMN NewsFeed,
18 May 2007:
Biopharmaceuticals, Generics, FDA[KV Pharmaceutical, metoprolol, AstraZeneca, Toprol]
FDA Approves Astrazeneca's Once-Daily Seroquel XR(TM) Extended-Release Tablets for the Treatment of Schizophrenia
HSMN NewsFeed,
18 May 2007:
Biopharmaceuticals, FDA[AstraZeneca, SEROQUEL XR, SEROQUEL, schizophrenia]
FDA Advisory Committee Recommends Expanded Use of FluMist(R)
HSMN NewsFeed,
16 May 2007:
Biopharmaceuticals, FDA[MedImmune, FluMist, Influenza Virus Vaccine]
MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
HSMN NewsFeed,
8 May 2007:
Biopharmaceuticals[MedImmune, Numax, motavizumab, respiratory syncytial virus]
AstraZeneca to Begin Construction for $100M Research Investment at R&D Boston; Expansion Solidifies Company's Commitment to Massachusetts as a Scientific and Biotech Hub
HSMN NewsFeed,
7 May 2007:
Biopharmaceuticals[AstraZeneca]
Royalty Pharma Acquires a Portion of New York University's Royalty Interest in Remicade(R) for $650 Million
HSMN NewsFeed,
4 May 2007:
Biopharmaceuticals[Royalty Pharma, Remicade]
James M. Cornelius Elected Bristol-Myers Squibb CEO
HSMN NewsFeed,
26 Apr 2007:
Biopharmaceuticals, Personnel[Bristol-Myers Squibb]
Astrazeneca to Acquire Medimmune for $58 Per Share in a Fully Recommended, All-Cash Transaction with a Total Enterprise Value of $15.2 Billion
HSMN NewsFeed,
23 Apr 2007:
Biopharmaceuticals, Mergers & Acquisitions[AstraZeneca, MedImmune]
Novacea Acquires Worldwide Development and Commercialization Rights for Its Oncology Candidate AQ4N
HSMN NewsFeed,
19 Apr 2007:
Biopharmaceuticals, Oncology, Licensing[Novacea, KuDOS Pharmaceuticals, AstraZeneca, AQ4N, banoxantrone]
Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade(TM) in the European Union
HSMN NewsFeed,
18 Apr 2007:
Biopharmaceuticals, Devices, Cardiology[Vasogen, Grupo Ferrer, Celacade]
Novartis Completes Its Business Portfolio Restructuring, Divesting Gerber for USD 5.5 Billion to Nestlé
HSMN NewsFeed,
12 Apr 2007:
Biopharmaceuticals, Personnel[Novartis]
TOPIGEN Expands Executive Team With Senior Business Development and Pharmaceutical Development Appointments
HSMN NewsFeed,
10 Apr 2007:
Biopharmaceuticals, Personnel[TOPIGEN]
First Study to Show Positive Benefit on Atherosclerosis for People With Early Signs of Diseased Arteries
HSMN NewsFeed,
25 Mar 2007:
Biopharmaceuticals, Cardiology[AstraZeneca, CRESTOR, rosuvastatin, atherosclerosis]
AVANIR Pharmaceuticals Appoints New Chief Executive Officer
HSMN NewsFeed,
14 Mar 2007:
Biopharmaceuticals, Personnel[ AVANIR Pharmaceuticals]
Authentix(R) Partners with AstraZeneca to Protect Drug Supply with Unit-Level Mass Serialisation
HSMN NewsFeed,
7 Mar 2007:
Biopharmaceuticals[Authentix, AstraZeneca]
AVANIR Pharmaceuticals Summarizes Outcome of FDA Meeting on Zenvia NDA
HSMN NewsFeed,
28 Feb 2007:
Biopharmaceuticals, FDA[AVANIR Pharmaceuticals, Zenvia, IEED, involuntary emotional expression disorder]
Aspirin Significantly Reduces Esophageal-Cancer Risk in People With Most- Aggressive Form of Barrett's Esophagus
HSMN NewsFeed,
27 Feb 2007:
Biopharmaceuticals, Oncology[Barrett's esophagus, esophageal cancer]
AstraZeneca Announces New Phase III Study of Vandetanib (ZACTIMA(R), ZD6474) in Patients With Advanced Lung Cancer
HSMN NewsFeed,
26 Feb 2007:
Biopharmaceuticals, Oncology[AstraZeneca, ZACTIMA, vandetanib, non-small cell lung cancer]
Dynavax Reports Interim, One-Year Data From Ragweed Allergy Trial at AAAAI
HSMN NewsFeed,
23 Feb 2007:
Biopharmaceuticals[Dynavax Technologies, TOLAMBA]
Tapestry Pharmaceuticals Appoints Sandra L. Silberman, M.D., Ph.D. As Chief Medical Officer
HSMN NewsFeed,
20 Feb 2007:
Biopharmaceuticals, Personnel[Tapestry Pharmaceuticals]
AVANIR Pharmaceuticals Hires Martin J. Sturgeon as Vice President and Chief Accounting Officer
HSMN NewsFeed,
12 Feb 2007:
Biopharmaceuticals, Personnel[AVANIR Pharmaceuticals]
AtheroGenics Announces Promotion of Charles A. Deignan to Vice President of Finance and Administration
HSMN NewsFeed,
6 Feb 2007:
Biopharmaceuticals, Personnel[AtheroGenics]
AstraZeneca Licenses Regeneron's VelocImmune(R) Technology for Discovering Human Monoclonal Antibodies
HSMN NewsFeed,
5 Feb 2007:
Biopharmaceuticals, Licensing[Regeneron Pharmaceuticals, AstraZeneca]
AstraZeneca Acquires Arrow Therapeutics To Broaden Anti-Infective Capabilities
HSMN NewsFeed,
1 Feb 2007:
Biopharmaceuticals, Mergers & Acquisitions[Arrow Therapeutics, Arrow Therapeutics]
AVANIR Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
HSMN NewsFeed,
30 Jan 2007:
Biopharmaceuticals, FDA[AVANIR Pharmaceuticals, FazaClo, clozapine]
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to Develop and Commercialize Diabetes Compounds
HSMN NewsFeed,
11 Jan 2007:
Biopharmaceuticals, Endocrinology[Bristol-Myers Squibb, AstraZeneca, Saxagliptin, diabetes]
POZEN Names Gilda M. Thomas as Senior Vice President and General Counsel
HSMN NewsFeed,
10 Jan 2007:
Biopharmaceuticals, Personnel[POZEN]
Cambridge Antibody Technology Licenses Monoclonal Antibody (CAT-213) for Treatment of Allergy Disorders to iCo Therapeutics
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Licensing[Cambridge Antibody Technology, iCo Therapeutics, CAT-213]
Jon P. Stonehouse Appointed Chief Executive Officer of BioCryst
HSMN NewsFeed,
8 Jan 2007:
Biopharmaceuticals, Personnel[BioCryst Pharmaceuticals]
Ranbaxy Granted Final U.S. FDA Approval to Manufacture and Market Atenolol Tablets
HSMN NewsFeed,
2 Jan 2007:
Biopharmaceuticals, Generics, FDA[Ranbaxy Pharmaceuticals, Atenolol, Tenormin, AstraZeneca]
Targacept to Receive $20 Million Milestone Payment as AstraZeneca Plans to Continue Development of AZD3480 (TC-1734)
HSMN NewsFeed,
27 Dec 2006:
Biopharmaceuticals, Neurology[Targacept, AstraZeneca, AZD3480, Alzheimer's disease, schizophrenia]
Dynavax Initiates Pivotal Phase 3 Trial for HEPLISAV(TM), Hepatitis B Vaccine
HSMN NewsFeed,
20 Dec 2006:
Biopharmaceuticals[Dynavax Technologies, HEPLISAV, hepatitis B, PHAST, Engerix-B]
Data Presented Today Show ARIMIDEX(R) Combined With Herceptin(R) Extended Progression-Free Survival in Patients With Advanced HER-2-Positive and Hormone Receptor-Positive Breast Cancer
HSMN NewsFeed,
14 Dec 2006:
Biopharmaceuticals, Oncology[AstraZeneca, ARIMIDEX, anastrozole, breast cancer]
Pozen Expects to Submit Revised Response to Trexima(TM) (Sumatriptan/Naproxen Sodium) Approvable Letter by Year End
HSMN NewsFeed,
13 Dec 2006:
Biopharmaceuticals, FDA[POZEN, Trexima, Sumatriptan, Naproxen, migraine]
Merck Remains Confident in Future Growth as it Executes on New Strategy
HSMN NewsFeed,
12 Dec 2006:
Biopharmaceuticals[Merck, GARDASIL, JANUVIA]
Abraxis BioScience to Present Data from Six Studies at San Antonio Breast Cancer Symposium
HSMN NewsFeed,
11 Dec 2006:
Biopharmaceuticals, Oncology[Abraxis BioScience, ABRAXANE, paclitaxel, Breast Cancer]
Cambridge Antibody Technology Announces Senior Management Promotions
HSMN NewsFeed,
8 Dec 2006:
Biopharmaceuticals, Personnel[Cambridge Antibody Technology]
Cephalon, Inc. Appoints Dr. Raj Khankari as General Manager of CIMA LABS
HSMN NewsFeed,
4 Dec 2006:
Biopharmaceuticals, Personnel[Cephalon, CIMA LABS]
Cubist Pharmaceuticals Licenses Rights for Development and Commercialization of CUBICIN in China to AstraZeneca
HSMN NewsFeed,
4 Dec 2006:
Biopharmaceuticals, Licensing[Cubist Pharmaceuticals, AstraZeneca, CUBICIN, daptomycin]
AstraZeneca's Statement on the Cost-Effectiveness Findings of the Clinical Antipsychotic Trials of Intervention Effectiveness-Schizophrenia (CATIE-SZ)
HSMN NewsFeed,
1 Dec 2006:
Biopharmaceuticals[AstraZeneca, CATIE trial, CATIE-SZ]
Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Shows Statistically Significant Results in Phase 3 Trial
HSMN NewsFeed,
28 Nov 2006:
Biopharmaceuticals[Dynavax Technologies, HEPLISAV, hepatitis B]
AstraZeneca Announces Distribution Agreement With Par Pharmaceutical for an Authorized Generic Version of TOPROL-XL(R)
HSMN NewsFeed,
21 Nov 2006:
Biopharmaceuticals, Generics, Distribution[AstraZeneca, Par Pharmaceutical, metoprolol, TOPROL-XL]
Par Pharmaceutical Begins Shipment of Generic TOPROL-XL(R)
HSMN NewsFeed,
21 Nov 2006:
Biopharmaceuticals, Generics, Distribution[Par Pharmaceutical, TOPROL-XL, AstraZeneca, metoprolol]
Celtic Pharma Appoints Two New Senior Executives
HSMN NewsFeed,
21 Nov 2006:
Biopharmaceuticals, Personnel[Celtic Pharma]
Approved Asthma Therapy SYMBICORT Improves Lung Function Safely and Effectively
HSMN NewsFeed,
13 Nov 2006:
Biopharmaceuticals[AstraZeneca, SYMBICORT, asthma]
Once- or Twice-Daily Treatment With PULMICORT RESPULES(R) (budesonide inhalation suspension) Significantly Increased Percentage of Days Asthma Is Controlled
HSMN NewsFeed,
13 Nov 2006:
Biopharmaceuticals[AstraZeneca, PULMICORT RESPULES, budesonide, asthma]
Targacept Announces Positive Results of Phase II Clinical Trial in Major Depression
HSMN NewsFeed,
9 Nov 2006:
Biopharmaceuticals[Targacept, mecamylamine, TRIDMAC, major depression]
Neurobiological Technologies, Inc. Comments on Recent Stroke Trial Developments
HSMN NewsFeed,
9 Nov 2006:
Biopharmaceuticals, Neurology[Neurobiological Technologies, Viprinex, ancrod, stroke]
POZEN Submits Full Response to FDA Approvable Letter For Trexima(TM)
HSMN NewsFeed,
9 Nov 2006:
Biopharmaceuticals, FDA[POZEN, Trexima, sumatriptan, RT Technology, naproxen, migraine]
Abbott to Expand Presence in Lipid Management Market With Acquisition of Kos Pharmaceuticals
HSMN NewsFeed,
6 Nov 2006:
Biopharmaceuticals, Mergers & Acquisitions[Abbott, Kos Pharmaceuticals]
AstraZeneca Appoints Howard Hutchinson as Chief Medical Officer
HSMN NewsFeed,
1 Nov 2006:
Biopharmaceuticals, Personnel[AstraZeneca]
AVANIR Receives FDA Approvable Letter for Zenvia for the Treatment of Involuntary Emotional Expression Disorder
HSMN NewsFeed,
31 Oct 2006:
Biopharmaceuticals, FDA[AVANIR Pharmaceuticals, Zenvia, Neurodex, IEED]
Royalty Pharma Announces Agreement Regarding the Purchase of the Rights to a Pre-Existing Royalty Interest in HUMIRA(R) From AstraZeneca and CAT
HSMN NewsFeed,
26 Oct 2006:
Biopharmaceuticals[Royalty Pharma, Abbott, AstraZeneca, HUMIRA, adalimumab]
NXY-059 Does Not Meet Efficacy Endpoints in Phase III Trial for Acute Ischemic Stroke
HSMN NewsFeed,
26 Oct 2006:
Biopharmaceuticals, Neurology[Renovis, NXY-059, SAINT II study, AstraZeneca, stroke]
FDA Approves New Formulation for NEXIUM
HSMN NewsFeed,
24 Oct 2006:
Biopharmaceuticals, Gastroenterology, FDA[AstraZeneca, proton pump inhibitor, NEXIUM, esomeprazole, GERD]
FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression Treatment
HSMN NewsFeed,
20 Oct 2006:
Biopharmaceuticals, FDA[AstraZeneca, SEROQUEL, quetiapine, bipolar disorder]
InfaCare Pharmaceutical Appoints Dr. Ronald Dundore, Vice President of Regulatory and Quality Affairs
HSMN NewsFeed,
16 Oct 2006:
Biopharmaceuticals, Personnel[InfaCare Pharmaceutical]
FDA Approves NEXIUM for the Treatment of Zollinger-Ellison Syndrome
HSMN NewsFeed,
12 Oct 2006:
Biopharmaceuticals, Gastroenterology, FDA[AstraZeneca, NEXIUM, esomeprazole, Zollinger-Ellison Syndrome]
NEW ENGLAND JOURNAL OF MEDICINE Reports Positive Results From Dynavax' Ragweed Allergy Therapy Trial
HSMN NewsFeed,
4 Oct 2006:
Biopharmaceuticals[Dynavax Technologies, Allergic Rhinitis, TOLAMBA]
Cerimon Pharmaceuticals Names Timothy J. McBride as Senior Vice President of Business Development
HSMN NewsFeed,
28 Sep 2006:
Biopharmaceuticals, Personnel[Cerimon Pharmaceuticals]
Precision Optics Corporation Announces Additions to its Senior Management
HSMN NewsFeed,
20 Sep 2006:
Devices, Personnel[Precision Optics Corp]
New Analysis Shows Patients Who Treat Their Migraine Pain Early With Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Have Higher Sustained Pain-Free Rates Than Those Who Treat Late
HSMN NewsFeed,
20 Sep 2006:
Biopharmaceuticals[POZEN, GlaxoSmithKline, Migraine, Trexima]
New Data Show Consistent Efficacy and Tolerability of Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Across Multiple Migraine Attacks
HSMN NewsFeed,
20 Sep 2006:
Biopharmaceuticals[POZEN, GlaxoSmithKline, Trexima, sumatriptan, migraine]
New Data Show Peak Concentration of Sumatriptan Occurred Earlier With Trexima(TM) (Sumatriptan Succinate/Naproxen Sodium) Compared to Imitrex(R) (Sumatriptan Succinate)
HSMN NewsFeed,
20 Sep 2006:
Biopharmaceuticals[POZEN, GlaxoSmithKline, sumatriptan, Trexima, Imitrex, migraine]
U.S. Court of Appeals Denies Rehearing Request in Dismissal of Tamoxifen Citrate Antitrust Lawsuits
HSMN NewsFeed,
18 Sep 2006:
Biopharmaceuticals, Oncology, Generics, Litigation[Barr Pharmaceuticals, Tamoxifen, AstraZeneca, Nolvadex]
Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer Drug
HSMN NewsFeed,
15 Sep 2006:
Biopharmaceuticals, Oncology[Schering AG, AstraZeneca, selective estrogen receptor downregulator]
Metastatix Completes Series a Financing
HSMN NewsFeed,
7 Sep 2006:
Biopharmaceuticals, Venture Capital[H.I.G. Ventures, Metastatix]
Dynavax Establishes Collaboration for TLR-9 Agonists for Asthma and COPD With AstraZeneca
HSMN NewsFeed,
6 Sep 2006:
Biopharmaceuticals, Licensing[Dynavax Technologies, AstraZeneca, TLR-9, COPD]
SkyePharma and Mundipharma Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in Europe
HSMN NewsFeed,
6 Sep 2006:
Biopharmaceuticals, Licensing[SkyePharma, Mundipharma, Flutiform]
New EXPLORER Results Show Patients Achieved Dramatic Reductions in C-Reactive Protein And LDL-C Levels With CRESTOR Combination Therapy
HSMN NewsFeed,
6 Sep 2006:
Biopharmaceuticals, Cardiology[AstraZeneca, CRESTOR, rosuvastatin, ezetimibe, C-reactive protein]
InNexus Biotechnology Names New CEO
HSMN NewsFeed,
1 Sep 2006:
Biopharmaceuticals, Personnel[InNexus Biotechnology]
Callisto Pharmaceuticals Announces Appointment of Robert C. Shepard, M.D., F.A.C.P., as Chief Medical Officer
HSMN NewsFeed,
8 Aug 2006:
Biopharmaceuticals, Personnel[Callisto Pharmaceuticals]
AVANIR Pharmaceuticals Hires Theresa Hope-Reese as Vice President of Human Resources
HSMN NewsFeed,
7 Aug 2006:
Biopharmaceuticals, Personnel[AVANIR Pharmaceuticals]
POZEN and AstraZeneca Announce Global Collaboration to Co-Develop and Commercialize Fixed Dose Combinations of Naproxen and Esomeprazole for the Treatment of Pain
HSMN NewsFeed,
2 Aug 2006:
Biopharmaceuticals[POZEN, AstraZeneca, proton pump inhibitor, esomeprazole, naproxen]
Aromatase Inhibitors Declared Superior to Tamoxifen in the Adjuvant Treatment of Early Breast Cancer
HSMN NewsFeed,
1 Aug 2006:
Biopharmaceuticals, Oncology[AstraZeneca, aromatase inhibitor, ARIMIDEX, anastrozole, breast cancer]
NEXIUM(R) Maintains Healing of Erosive Esophagitis Better Than Lansoprazole, New Study Shows
HSMN NewsFeed,
25 Jul 2006:
Biopharmaceuticals, Gastroenterology[AstraZeneca, NEXIUM, esomeprazole, lansoprazole, Prevacid]
AstraZeneca Submits NDA for Sustained Release Formulation of SEROQUEL(R) for Schizophrenia Treatment
HSMN NewsFeed,
18 Jul 2006:
Biopharmaceuticals, FDA[AstraZeneca, SEROQUEL, quetiapine fumarate, schizophrenia]
AtheroGenics Announces Promotion of Joseph M. Gaynor, Jr. to Senior Vice President
HSMN NewsFeed,
6 Jul 2006:
Biopharmaceuticals, Personnel[AtheroGenics]
Abbott and AstraZeneca Announce Collaboration to Develop and Commercialize CRESTOR(R) and Next-Generation TriCor(R) (ABT-335) Fixed-Dose Combination
HSMN NewsFeed,
5 Jul 2006:
Biopharmaceuticals, Cardiology[Abbott, AstraZeneca, CRESTOR, rosuvastatin, TriCor , fenofibrate]
Abraxis BioScience Completes Acquisition of the AstraZeneca U.S. Branded Anesthetic and Analgesic Product Lines
HSMN NewsFeed,
28 Jun 2006:
Biopharmaceuticals, Acquisitions[Abraxis BioScience, AstraZeneca, Diprivan, Xylocaine, Naropin, Astramorph]
New Data Shows CRESTOR(R) Helped African American, Hispanic American and South Asian American Patients Significantly Lower LDL-C and Achieve Cholesterol Goals
HSMN NewsFeed,
22 Jun 2006:
Biopharmaceuticals, Cardiology[AstraZeneca, CRESTOR, rosuvastatin]
OXiGENE Appoints Chief Medical Officer, Dr. Peter Harris
HSMN NewsFeed,
14 Jun 2006:
Biopharmaceuticals, Personnel[OXiGENE]
NPS Announces Aggressive Plan to Restructure Operations and Cut Costs
HSMN NewsFeed,
12 Jun 2006:
Biopharmaceuticals[NPS Pharmaceuticals]
Perrigo Announces Participation in Dexcel's Filing for Generic Version of Prilosec OTC(R)
HSMN NewsFeed,
7 Jun 2006:
Biopharmaceuticals, Generics[Perrigo, Dexcel Pharma Technologies, Prilosec OTC, omeprazole, AstraZeneca]
ENTOCORT(R) EC (budesonide) Capsules Recommended by the American Gastroenterology Association as First-Line Therapy for the Treatment of Mild-to-Moderate Crohn's Disease
HSMN NewsFeed,
5 Jun 2006:
Biopharmaceuticals, Gastroenterology[Prometheus Laboratories, ENTOCORT EC, Crohn's disease, budesonide]
New Data Show That Five Years of Treatment With Arimidex(R) (anastrozole) Did Not Cause Osteoporosis in Early Breast Cancer Patients With Normal Bone Mineral Density at Outset
HSMN NewsFeed,
3 Jun 2006:
Biopharmaceuticals[AstraZeneca, ARIMIDEX, anastrozole, ATAC trial]
Abraxis BioScience Appoints New Officers to Executive Management Team
HSMN NewsFeed,
25 May 2006:
Biopharmaceuticals, Personnel[Abraxis BioScience]
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
HSMN NewsFeed,
25 May 2006:
Biopharmaceuticals, Personnel[Abraxis BioScience]
Dr. Gerard T. Kennealey Joins MGI PHARMA as Senior Vice President, Clinical Development
HSMN NewsFeed,
25 May 2006:
Biopharmaceuticals, Personnel[MGI PHARMA]
AVANIR Completes the Acquisition of Alamo Pharmaceuticals
HSMN NewsFeed,
24 May 2006:
Biopharmaceuticals, Mergers & Acquisitions[AVANIR Pharmaceuticals, Alamo Pharmaceuticals, FazaClo, clozapine]
Dyax Announces the Appointment of Peggy Berry as Senior Vice President of Quality and Regulatory Affairs
HSMN NewsFeed,
24 May 2006:
Biopharmaceuticals, Personnel[Dyax Corp]
AtheroGenics Names Brian Blakey as Vice President of Marketing
HSMN NewsFeed,
24 May 2006:
Biopharmaceuticals, Personnel[AtheroGenics]
Second Investigational Study of SEROQUEL(R) in the Treatment of Depressive Episodes Associated with Bipolar Disorder Confirms Previous Findings
HSMN NewsFeed,
23 May 2006:
Biopharmaceuticals[AstraZeneca, SEROQUEL, BOLDER II, quetiapine]
AVANIR Announces the Intended Acquisition of a Private Specialty Pharmaceutical Company
HSMN NewsFeed,
23 May 2006:
Biopharmaceuticals, Mergers & Acquisitions[AVANIR Pharmaceuticals, Alamo Pharmaceuticals, FazaClo, clozapine]
New Studies Examine SEROQUEL(R) in Combination With Antidepressant Therapy in Patients With Depression
HSMN NewsFeed,
22 May 2006:
Biopharmaceuticals[AstraZeneca, SEROQUEL, quetiapine]
Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome
HSMN NewsFeed,
22 May 2006:
Biopharmaceuticals, Gastroenterology[AstraZeneca, NEXIUM, esomeprazole, Zollinger-Ellison syndrome]
New Study Shows Erosive Esophagitis Healing Linked to Gastric Acid Control
HSMN NewsFeed,
22 May 2006:
Biopharmaceuticals, Gastroenterology[AstraZeneca, NEXIUM, esomeprazole, GERD]
Targacept Announces Positive Phase II Results for TC-1734 (AZD3480) in Memory Impaired Older Subjects
HSMN NewsFeed,
19 May 2006:
Biopharmaceuticals, Neurology[Targacept, TC-1734, AZD3480, Alzheimer's disease, AstraZeneca]
Renovis Names Donald R. Joseph as Senior Vice President, Corporate Development and General Counsel
HSMN NewsFeed,
17 May 2006:
Biopharmaceuticals, Personnel[Renovis]
CRESTOR Helped More Patients Reach Goal in MERCURY II Study
HSMN NewsFeed,
15 May 2006:
Biopharmaceuticals, Cardiology[AstraZeneca, CRESTOR, rosuvastatin, MERCURY II]
PDI, Inc. Announces a Significant New Contract Sales Engagement With a Major Pharmaceutical Company
HSMN NewsFeed,
11 May 2006:
Biopharmaceuticals[PDI]
AtheroGenics Announces Promotions of Three Senior Executives
HSMN NewsFeed,
11 May 2006:
Biopharmaceuticals, Personnel[AtheroGenics]
Astex Announces New Chief Executive Officer
HSMN NewsFeed,
10 May 2006:
Biopharmaceuticals, Personnel[Astex Therapeutics, Leon Bushara]
YM Biosciences completes acquisition of Eximias
HSMN NewsFeed,
9 May 2006:
Biopharmaceuticals, Oncology, Mergers & Acquisitions[YM BioSciences, Eximias Pharmaceutical]
AVANIR Pharmaceuticals Hires Michael J. Puntoriero to Serve as Senior Vice President of Finance and Chief Financial Officer
HSMN NewsFeed,
8 May 2006:
Biopharmaceuticals, Personnel[AVANIR Pharmaceuticals]
Kos and SkyePharma Sign Exclusive License Agreement for the Marketing and Distribution of Flutiform(TM) in the United States
HSMN NewsFeed,
8 May 2006:
Biopharmaceuticals, Licensing, Distribution[ Kos Pharmaceuticals, Jagotec, SkyePharma, Flutiform]
SkyePharma and Kos Announce Exclusive Licence Agreement for Marketing and Distribution of Flutiform(TM) in the United States
HSMN NewsFeed,
8 May 2006:
Biopharmaceuticals, Licensing, Distribution[SkyePharma, Kos Pharmaceuticals, Flutiform]
Combined Use of ATACAND(R) (candesartan cilexetil) and ACE Inhibitor Improves Heart Failure Outcomes More Than ACE Inhibitor Alone
HSMN NewsFeed,
4 May 2006:
Biopharmaceuticals, Cardiology[AstraZeneca, ATACAND, candesartan cilexetil]
Biovail to Promote AstraZeneca's Zoladex(R) 3.6mg (Goserelin Acetate Implant) for Endometriosis in the United States and Puerto Rico
HSMN NewsFeed,
2 May 2006:
Biopharmaceuticals, Drug Delivery[Biovail, AstraZeneca, Zoladex, goserelin, Endometriosis]
FDA Approves Use of NEXIUM(R) in Children Ages 12 to 17 For Short-Term Treatment of GERD
HSMN NewsFeed,
1 May 2006:
Biopharmaceuticals, FDA[AstraZeneca, NEXIUM, esomeprazole]
AVANIR Announces Neurodex Phase III Trial Results Published in Annals of Neurology
HSMN NewsFeed,
28 Apr 2006:
Biopharmaceuticals, Neurology[AVANIR Pharmaceuticals, Neurodex, IEED, pseudobulbar affect, emotional lability]
Abraxis BioScience Announces Co-Promotion Agreement with AstraZeneca for ABRAXANE(R) in the U.S. and the Acquisition of AstraZeneca's U.S. Branded Anesthetic and Analgesic Product Lines
HSMN NewsFeed,
27 Apr 2006:
Biopharmaceuticals, Acquisitions[Abraxis BioScience, AstraZeneca, ABRAXANE]
Novel Study Published in New England Journal of Medicine Evaluates Effects of ATACAND(R) (candesartan cilexetil) in Patients With Prehypertension
HSMN NewsFeed,
20 Apr 2006:
Biopharmaceuticals[AstraZeneca, ATACAND, candesartan cilexetil, Prehypertension]
AVANIR's Neurodex NDA Accepted with Priority Review for Involuntary Emotional Expression Disorder
HSMN NewsFeed,
4 Apr 2006:
Biopharmaceuticals, Neurology, FDA[AVANIR Pharmaceuticals, Neurodex, IEED, pseudobulbar affect]
CuraGen Appoints Dr. Frank M. Armstrong as Chief Executive Officer
HSMN NewsFeed,
30 Mar 2006:
Biopharmaceuticals, Personnel[CuraGen]
First-Ever Large-Scale Prospective Study in Hispanic Patients With Elevated Cholesterol Demonstrates Significant Cholesterol Reductions With CRESTOR(R)
HSMN NewsFeed,
24 Mar 2006:
Biopharmaceuticals[AstraZeneca, CRESTOR, rosuvastatin, STARSHIP trial]
NEXIUM(R) Shown to Reduce Gastric Ulcers in At-Risk Patients Using Long-Term NSAIDs
HSMN NewsFeed,
22 Mar 2006:
Biopharmaceuticals, Gastroenterology[AstraZeneca, NEXIUM, esomeprazole, nonsteroidal anti-inflammatory drugs]
BARRX Medical, Inc. Initiates Landmark Study Comparing Two Treatment Options for Barrett's Esophagus
HSMN NewsFeed,
20 Mar 2006:
Devices, Biopharmaceuticals, Gastroenterology[BARRX Medical, AstraZeneca, radio frequency ablation, Barrett's Esophagus]
Headline Results From CHANT Safety and Tolerability Study In Intracerebral Hemorrhage (ICH) Show NXY-059 Achieved Key Endpoints
HSMN NewsFeed,
14 Mar 2006:
Biopharmaceuticals, Neurology[AstraZeneca, Renovis, CHANT trial, NXY-059, intracerebral hemorrhage]
Renovis Announces That Headline Results From CHANT Safety and Tolerability Trial in Intracerebral Hemorrhage (ICH) Show NXY-059 Achieved Key Endpoints
HSMN NewsFeed,
14 Mar 2006:
Biopharmaceuticals, Neurology[Renovis, CHANT trial, NXY-059, intracerebral hemorrhage, AstraZeneca]
New Data Presented at American College of Cardiology Meeting Compares the AstraZeneca Investigational Drug AZD6140 to Clopidogrel for Inhibition of Platelet Aggregation
HSMN NewsFeed,
13 Mar 2006:
Biopharmaceuticals, Cardiology[AstraZeneca, AZD6140, DISPERSE2 study]
AstraZeneca Commences Patent Infringement Litigation Against IVAX
HSMN NewsFeed,
8 Mar 2006:
Biopharmaceuticals, Generics, Litigation[AstraZeneca, IVAX Corp, Teva Pharmaceutical, NEXIUM, esomeprazole]
AVANIR Pharmaceuticals Hires Matthew R. Ruth as Vice President of Sales
HSMN NewsFeed,
1 Mar 2006:
Biopharmaceuticals, Personnel[AVANIR Pharmaceuticals]
PDI, Inc. Announces Termination of AstraZeneca Fee-for-Service Contract Sales Programs
HSMN NewsFeed,
28 Feb 2006:
Biopharmaceuticals[PDI, AstraZeneca]
Kos Reports Summary Results of Key Phase IV Research and Development Studies
HSMN NewsFeed,
23 Feb 2006:
Biopharmaceuticals[Kos Pharmaceuticals, Niaspan, COMPELL Study]
Study Finds Cymbalta(R) Was As Safe And Well-Tolerated As Routine Drug Treatments For Diabetic Nerve Pain
HSMN NewsFeed,
14 Feb 2006:
Biopharmaceuticals[Eli Lilly, Cymbalta, duloxetine]
New England Journal of Medicine Publishes NXY-059 Study, the First International Study of a Neuroprotectant to Show Reduced Disability Following Acute Ischemic Stroke
HSMN NewsFeed,
8 Feb 2006:
Biopharmaceuticals, Neurology[Renovis, SAINT I trial, NXY-059, stroke, AstraZeneca, Cerovive]
NPS Announces Extension of R&D Collaboration With AstraZeneca
HSMN NewsFeed,
8 Feb 2006:
Biopharmaceuticals[NPS Pharmaceuticals, AstraZeneca, metabotropic glutamate receptors]
Targacept Announces Early Completion of Hart-Scott-Rodino Waiting Period for Agreement With AstraZeneca
HSMN NewsFeed,
6 Feb 2006:
Biopharmaceuticals, Licensing, Neurology[Targacept, AstraZeneca, TC-1734, AZD3480, Alzheimer's disease]
FDA Grants Fast Track Designation for the Investigation of ZACTIMA(TM) (ZD6474) for the Treatment of Thyroid Cancer
HSMN NewsFeed,
2 Feb 2006:
Biopharmaceuticals, Oncology, FDA[AstraZeneca, fast track designation, ZACTIMA, medullary thyroid cancer]
Iconix Pharmaceuticals Names New Head of Business Development
HSMN NewsFeed,
2 Feb 2006:
Biopharmaceuticals[Iconix Pharmaceuticals, Cate Sabatini]
AVANIR Submits Expanded Neurodex New Drug Application for the Treatment of Involuntary Emotional Expression Disorder
HSMN NewsFeed,
30 Jan 2006:
Biopharmaceuticals, FDA[AVANIR Pharmaceuticals, Neurodex, dextromethorphan, quinidine]
Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer
HSMN NewsFeed,
20 Jan 2006:
Biopharmaceuticals, Personnel[AXCAN PHARMA]
KV Pharmaceutical Company Wins Summary Judgment in Patent Litigation With AstraZeneca
HSMN NewsFeed,
18 Jan 2006:
Biopharmaceuticals, Generics, Litigation[KV Pharmaceutical, metoprolol, Toprol, AstraZeneca]
Andrx Granted Summary Judgment for Generic Toprol-XL
HSMN NewsFeed,
18 Jan 2006:
Biopharmaceuticals, Generics, Litigation[Andrx, Toprol-XL, metoprolol, AstraZeneca]
AstraZeneca and M. D. Anderson Cancer Center Form Umbrella Scientific Collaboration Agreements
HSMN NewsFeed,
12 Jan 2006:
Biopharmaceuticals, Oncology[AstraZeneca, M. D. Anderson Cancer Center]
AVANIR Licenses Docosanol 10% Cream in Japan
HSMN NewsFeed,
11 Jan 2006:
Biopharmaceuticals, Licensing, Distribution[AVANIR Pharmaceuticals, docosanol]
AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs
HSMN NewsFeed,
11 Jan 2006:
Biopharmaceuticals, Personnel[AVANIR Pharmaceuticals]
AstraZeneca Submits sNDA for SEROQUEL(R) for Bipolar Depression Treatment
HSMN NewsFeed,
3 Jan 2006:
Biopharmaceuticals, FDA[AstraZeneca, SEROQUEL, quetiapine]
Additional items found: The Network Archive contains
331 additional itemsAstraZeneca
Public
Feeds 
Full text >>